Wang Shuyue, Guo Fei, Sun Xiaochen, Song Xiao, Yuan Yaohui, Zhang Chao, Lin Guitao, Sheng Huagang
School of Pharmaceutical Sciences, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Evid Based Complement Alternat Med. 2021 Jan 8;2021:8862176. doi: 10.1155/2021/8862176. eCollection 2021.
Hypertensive vascular remodeling (HVR) is the pathophysiological basis of hypertension, which is also an important cause of vascular disease and target organ damage. Treatment with Fructus Tribuli (FT), a traditional Chinese medicine, has a positive effect on HVR. However, the pharmacological mechanisms of FT are still unclear. Therefore, this study aimed to reveal the potential mechanisms involved in the effects of FT on HVR based on network pharmacology and molecular docking.
We selected the active compounds and targets of FT according to the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and the Swiss Target Prediction database, and the targets of HVR were collected from the Online Mendelian Inheritance in Man (OMIM), GeneCards, and DrugBank databases. The protein-protein interaction network (PPI) was established using the STRING database. Moreover, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses and network analysis were performed to further explore the potential mechanisms. Finally, molecular docking methods were used to evaluate the affinity between the active compounds and the main target.
Seventeen active compounds of FT and 164 potential targets for the treatment of HVR were identified. Component-target and PPI networks were constructed, and 12 main active components and 33 main targets were identified by analyzing the topological parameters. Additionally, GO analysis indicated that the potential targets were enriched in 483 biological processes, 52 cellular components, and 110 molecular functions. KEGG analysis revealed that the potential targets were correlated with 122 pathways, such as the HIF-1 signaling pathway, ErbB signaling pathway, and VEGF signaling pathway. Finally, molecular docking showed that the 12 main active components had a good affinity for the top five main targets.
This study demonstrated the multiple compounds, targets, and pathway characteristics of FT in the treatment of HVR. The network pharmacology method provided a novel research approach to analyze potential mechanisms.
高血压血管重塑(HVR)是高血压的病理生理基础,也是血管疾病和靶器官损害的重要原因。中药刺蒺藜(FT)治疗对HVR有积极作用。然而,FT的药理机制仍不清楚。因此,本研究旨在基于网络药理学和分子对接揭示FT对HVR作用的潜在机制。
根据中药系统药理学数据库与分析平台(TCMSP)和瑞士靶点预测数据库选择FT的活性成分和靶点,从人类孟德尔遗传在线(OMIM)、基因卡片和药物银行数据库收集HVR的靶点。使用STRING数据库建立蛋白质-蛋白质相互作用网络(PPI)。此外,进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路分析以及网络分析以进一步探索潜在机制。最后,使用分子对接方法评估活性成分与主要靶点之间的亲和力。
鉴定出FT的17种活性成分和164个治疗HVR的潜在靶点。构建了成分-靶点和PPI网络,通过分析拓扑参数确定了12种主要活性成分和33个主要靶点。此外,GO分析表明潜在靶点富集于483个生物学过程、52个细胞成分和110个分子功能。KEGG分析显示潜在靶点与122条通路相关,如缺氧诱导因子-1信号通路、表皮生长因子受体(ErbB)信号通路和血管内皮生长因子(VEGF)信号通路。最后,分子对接表明12种主要活性成分与前五个主要靶点具有良好的亲和力。
本研究证明了FT治疗HVR的多种化合物、靶点和通路特征。网络药理学方法为分析潜在机制提供了一种新的研究途径。